Sep 7, 2022
Angel Scale Biotech: Learn More
Sherine Abdelmawla, PhD, founded Akanocure Pharmaceuticalsto combine chemistryand AI in a platform for discovering effective drugs that can be easily produced at scale. The first use case is a cancer therapy. Great chat with a compelling founder.
Sponsored by Purdue University entrepreneurship and Peter Fasse, patent attorney at Fish and Richardson.
Highlights:
- Sal Daher Introduces Sherine Abdelmawla
- What Akanocure Pharmaceuticals is Doing
- "... The challenge is ... logistically speaking, manufacturing antibodies, they have problems with pharmacokinetics. Can we have a small molecule that can do the job of that antibody? ..."
- Collaboration in the Lab Vs. Collaboration in the Field
- The Business Model for Akanocure
- "... interrupting the process that the cancer uses for hijacking the production of lipid fats to create its own version, a lipid shell that has particular features that make it really hard to detect the cancer..."
- Sherine's Backstory
- Why Research?
- “...Science is hard enough, but on top of it, doing science with inadequate resources…”
- Advice to the Audience
Topics: biotech, founding story, robotics/AI